Stay updated on Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe PubMed publications note was updated to clarify that publications are automatically filled from PubMed and may not be about the study, and a new 'Revision: v3.3.2' label was added.SummaryDifference0.0%

- Check30 days agoChange DetectedRemoved an administrative funding/update-status disclaimer from the page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe two Taiwan study locations were updated from 'Tainan City, Taiwan, 704' and 'Tainan City, Taiwan, 736' to 'Tainan, Taiwan, 704' and 'Tainan, Taiwan, 736' in the Locations section.SummaryDifference0.0%

- Check45 days agoChange DetectedObserved minor UI updates and a recent update timestamp, with no changes to core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check73 days agoChange Detected- Added a government notice about funding and operating status, and a new v3.2.0 revision tag. - Removed the previous v3.1.0 revision tag.SummaryDifference2%

- Check81 days agoChange DetectedVersion tag updated from v3.0.2 to v3.1.0; no substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Sorafenib in Advanced Hepatocellular Carcinoma Clinical Trial page.